Join Prof Andrea Fagiolini, Professor of Psychiatry from the University of Siena, as he gives his expert opinion on the benefits of partial agonists for schizophrenia and the practicalities of prescribing long-acting injectables including Abilify Maintena in clinical practice.
Abilify Maintena PBS Information: Authority required (STREAMLINED). Code: 4246 for schizophrenia.
This product is not listed on the PBS for the treatment of bipolar 1 disorder.
Please review Approved Product Information before prescribing.
Product Information is available by calling Lundbeck on 1300 721 277 or by clicking:
Abilify Maintena is a registered trademark of Otsuka Pharmaceutical Co., Ltd. Abilify Maintena is co-commercialised by Lundbeck Australia and Otsuka Australia Pharmaceutical Pty Limited.
